Table 5

Outcomes during index hospital stay for valve size and type, and for valve function and regurgitation to 6 weeks by group

Valve
characteristics
Mini-
sternotomy
group (n=135)
Conventional
sternotomy
group (n=135)
Mean
difference
(95% CI; p value)
Valve size: mm
 19–21 mm n (%)40 (29.6)38 (28.1)
 23–25 mm n (%)84 (62.2)80 (59.3)
 27–29 mm n (%)11 (8.2)17 (12.6)
 Mean±SD23.1±2.123.6±2.5
 Range (min–max)19.0–29.019.0–31.0
 Valve type: n (%)
 Biological and sutureless4 (3.0)3 (2.2)
 Biological prosthesis96 (71.1)98 (72.6)
 Mechanical prosthesis35 (25.9)34 (25.2)
Valve function
Mean gradient
Baseline
 n111*110*
 Mean±SD47.9±15.747.7±20.20.2 (−4.6 to 5.0)
 Min–max10–938–110
6 weeks
 n120*126*
 Mean±SD15.7±5.515.7±5.80.5†(−1.0 to 2.1)
 Min–max6–334–34
Peak gradient
Baseline
 n125*124*
 Mean±SD82.3±25.977.1±29.15.2 (−1.7 to 2.3)
 Min–max16–1528–173
6 weeks
 n130*130*
 Mean±SD29.9±10.529.7±10.8−0.3† (−2.9 to 2.3)
 Min–max12–6211–61
Aortic valve regurgitation
Nil/trivial
 n/n (%)109/134* (81.3)109/130* (83.8)218/264 (82.6)
Mild
 n/n (%)19/134* (14.2)18/130* (13.9)37/264 (14.0)
Moderate
 n/n (%)5/134* (3.7)2/130* (1.5)7/264 (2.7)
Severe
 n/n (%)1/134* (0.8)1/130* (0.8)2/264 (0.8)
  • *It was not possible to quantify valve function in all patients.

  • †After adjusting for randomisation factors and baseline data.